JNJ has been in the news 326% more than usual
Apr 09, 2025, 8:31 PM
3.16%
What does JNJ do
Johnson & Johnson, headquartered in New Brunswick, New Jersey, employs 131,900 people and focuses on healthcare through its Innovative Medicine and MedTech segments. Innovative Medicine targets various therapeutic areas, while MedTech offers products for orthopedic and cardiovascular interventions.
JNJ has been in the news recently: Johnson & Johnson's drug nipocalimab demonstrated sustained improvement in symptoms of generalized Myasthenia Gravis (gMG) and allowed 45% of steroid users to reduce their dosage over 84 weeks. Additionally, Goldman Sachs upgraded the company's stock to "buy," citing its robust pharmaceutical business and a potential price increase of 14.2%.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.